{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:39Z","timestamp":1787261019352,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["Framework Programme 7 HEALTH-2013-INNOVATION-2 grant number 601857"],"award-info":[{"award-number":["Framework Programme 7 HEALTH-2013-INNOVATION-2 grant number 601857"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_212584"],"award-info":[{"award-number":["310030_212584"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lanmic.2026.101470","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:04:04Z","timestamp":1787169844000},"page":"101470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-canonical phage\u2013bacterium interactions during topical phage therapy in the PhagoBurn clinical trial: a retrospective, observational, reverse translational study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6260-7269","authenticated-orcid":false,"given":"Camille","family":"Boross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Pitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kalbermatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Oberhaensli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Roder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Guggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Borghesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buelent","family":"Goezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8636-5427","authenticated-orcid":false,"given":"Jo\u00ebl L","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-4591","authenticated-orcid":false,"given":"Gr\u00e9gory","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3247-2283","authenticated-orcid":false,"given":"Cindy","family":"Fevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-5625","authenticated-orcid":false,"given":"David R","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9443-6101","authenticated-orcid":false,"given":"Yok-Ai","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2026.101470_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1473-3099(20)30464-3","article-title":"Bacteriophages: it\u2019s a medicine, Jim, but not as we know it","volume":"21","author":"Pirnay","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101470_bib2","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101470_bib3","article-title":"Progress and pitfalls of bacteriophage therapy in critical care: a concise definitive review","volume":"3","author":"Valente","year":"2021","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.lanmic.2026.101470_bib4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.lanmic.2026.101470_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101470_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lanmic.2026.101470_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial","volume":"21","author":"Leitner","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101470_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41564-023-01566-w","article-title":"Revitalizing antibiotic discovery and development through in vitro modelling of in-patient conditions","volume":"9","author":"Sollier","year":"2024","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.lanmic.2026.101470_bib9","doi-asserted-by":"crossref","first-page":"e956","DOI":"10.1016\/S2666-5247(22)00288-9","article-title":"Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis","volume":"3","author":"G\u00f3mez-Ochoa","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.lanmic.2026.101470_bib10","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210188","article-title":"Black box of phage\u2013bacterium interactions: exploring alternative phage infection strategies","volume":"11","author":"M\u00e4ntynen","year":"2021","journal-title":"Open Biol"},{"key":"10.1016\/j.lanmic.2026.101470_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad221","article-title":"Compassionate use of bacteriophages for failed persistent infections during the first 5 years of the Israeli phage therapy center","volume":"10","author":"Onallah","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.lanmic.2026.101470_bib12","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1099\/jgv.0.000883","article-title":"A carrier state is established in Pseudomonas aeruginosa by phage LeviOr01, a newly isolated ssRNA levivirus","volume":"98","author":"Pourcel","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.lanmic.2026.101470_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1099\/mic.0.000263","article-title":"Pseudolysogeny and sequential mutations build multiresistance to virulent bacteriophages in Pseudomonas aeruginosa","volume":"162","author":"Latino","year":"2016","journal-title":"Microbiology (Reading)"},{"key":"10.1016\/j.lanmic.2026.101470_bib14","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/v11121089","article-title":"Pseudomonas aeruginosa PA5oct jumbo phage impacts planktonic and biofilm population and reduces its host virulence","volume":"11","author":"Olszak","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.lanmic.2026.101470_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cpt.897","article-title":"Bedside to bench: integrating quantitative Clinical Pharmacology and reverse translation to optimize drug development","volume":"103","author":"Gibbs","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lanmic.2026.101470_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00621-22","article-title":"Mutation to ispA produces stable small-colony variants of Pseudomonas aeruginosa that have enhanced aminoglycoside resistance","volume":"66","author":"Pitton","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanmic.2026.101470_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02743-22","article-title":"Parallel evolution of Pseudomonas aeruginosa during a prolonged ICU-infection outbreak","volume":"10","author":"Cameron","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.lanmic.2026.101470_bib18","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1038\/s41467-018-07641-9","article-title":"High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries","volume":"9","author":"Jain","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.lanmic.2026.101470_bib19","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","article-title":"Biopython: freely available Python tools for computational molecular biology and bioinformatics","volume":"25","author":"Cock","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.lanmic.2026.101470_bib20","doi-asserted-by":"crossref","first-page":"W78","DOI":"10.1093\/nar\/gkae268","article-title":"Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool","volume":"52","author":"Letunic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.lanmic.2026.101470_bib21","first-page":"111","article-title":"Bacteriophage contamination: is there a simple method to reduce its deleterious effects in laboratory cultures and biotechnological factories?","volume":"45","author":"\u0141os","year":"2004","journal-title":"J Appl Genet"},{"key":"10.1016\/j.lanmic.2026.101470_bib22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.cell.2017.10.045","article-title":"Contemporary phage biology: from classic models to new insights","volume":"172","author":"Ofir","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.lanmic.2026.101470_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41579-021-00530-x","article-title":"Revisiting the rules of life for viruses of microorganisms","volume":"19","author":"Correa","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.lanmic.2026.101470_bib24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41579-022-00755-4","article-title":"Mutualistic interplay between bacteriophages and bacteria in the human gut","volume":"20","author":"Shkoporov","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.lanmic.2026.101470_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12915-021-01084-3","article-title":"Long-term persistence of crAss-like phage crAss001 is associated with phase variation in Bacteroides intestinalis","volume":"19","author":"Shkoporov","year":"2021","journal-title":"BMC Biol"},{"key":"10.1016\/j.lanmic.2026.101470_bib26","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chom.2025.07.004","article-title":"The prototypic crAssphage is a linear phage-plasmid","volume":"33","author":"Schmidtke","year":"2025","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lanmic.2026.101470_bib27","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.130200","article-title":"Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni","volume":"4","author":"Siringan","year":"2014","journal-title":"Open Biol"},{"key":"10.1016\/j.lanmic.2026.101470_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003269","article-title":"Expression of a novel P22 ORFan gene reveals the phage carrier state in Salmonella typhimurium","volume":"9","author":"Cenens","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.lanmic.2026.101470_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41564-025-02207-0","article-title":"Persistent virulent phages exist across bacterial isolates","volume":"11","author":"Dougherty","year":"2026","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.lanmic.2026.101470_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41564-025-02203-4","article-title":"Large-scale analysis of bacterial genomes reveals thousands of lytic phages","volume":"11","author":"Perfilyev","year":"2026","journal-title":"Nat Microbiol"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726001254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524726001254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:25:42Z","timestamp":1787257542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524726001254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S2666524726001254"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101470","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-canonical phage\u2013bacterium interactions during topical phage therapy in the PhagoBurn clinical trial: a retrospective, observational, reverse translational study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2026.101470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101470"}}